Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 17Thoracic 10Sarcoma 2Genitourinary 2Other solid neoplasm 1NET 1Head & Neck 1Gynecologic 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Neuroendocrine Tumors 130Gastro-enteropancreatic neuroendocrine tumor 16Pancreatic Neoplasms 14Neoplasms 12Stomach Neoplasms 8Carcinoma, Neuroendocrine 8Carcinoid Tumor 8Prostatic Neoplasms 7Lung Neoplasms 7Carcinoma, Hepatocellular 7Breast Neoplasms 7Thyroid Neoplasms 6Melanoma 6Esophageal Neoplasms 6Colonic Neoplasms 6Rectal Neoplasms 5Pheochromocytoma 5Neoplasm Metastasis 5Gastrointestinal Stromal Tumors 5Carcinoma 5Adenoma, Islet Cell 5Adenocarcinoma 5Testicular Neoplasms 4Skin Neoplasms 4Serotonin Syndrome 4Sarcoma 4Paraganglioma 4Liver Neoplasms 4Kidney Neoplasms 4Head and Neck Neoplasms 4

Interventions

telotristat ethyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cachexia × NET × Clear all
NCT04034745 2020-12-30

Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain

Cedars-Sinai Medical Center

Withdrawn
EndocrineGastrointestinalNET

Cachexia, Neoplasms, Pancreatic Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡